A recent study highlights the KLF5 gene as a potentially critical force behind the aggressive spread of pancreatic cancer, operating through an unexpected mechanism. Instead of causing mutations in DNA, KLF5 appears to reprogram how genes are turned on and off, an epigenetic process that significantly aids tumors in their growth and invasion of new areas. Researchers found that this gene plays a substantial role in metastatic cells and, furthermore, regulates other genes intrinsically linked to cancer progression. This groundbreaking discovery paves the way for the development of new treatments specifically designed to target the epigenetic “control system” that cancer exploits.
KLF5 Gene Identified as Key Epigenetic Driver of Pancreatic Cancer Spread
By Rupert Blackwood
Investigative journalist based in Sheffield, focusing on technology's impact on society. Rupert specializes in cybercrime's effect on communities, from online fraud targeting elderly residents to cryptocurrency scams. His reporting examines social media manipulation, digital surveillance, and how criminal networks operate in cyberspace. With expertise in computer systems, he connects technical complexity with real-world consequences for ordinary people